Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SLS · NASDAQ · Pharmaceutical Preparations
$13.66−1.20 (−8.08%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Sellas Life Sciences Group (SLS) · oqro.io/stocks/SLS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a new position in SLS (put options) for Q2 2026SourceInsider trade · Traded Jun 12, 2025 · Filed Jun 13, 2025
Director purchased ~$15K of SLS shares in the open marketSourceInsider trade · Traded May 30, 2025 · Filed Jun 2, 2025
Director purchased ~$34K of SLS shares in the open marketSourceInsider trade · Traded May 22, 2025 · Filed May 22, 2025
Director purchased ~$36K of SLS shares in the open marketSource